Cordasco Financial Network’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$59K Hold
700
0.04% 174
2022
Q1
$61K Hold
700
0.04% 175
2021
Q4
$61K Hold
700
0.04% 173
2021
Q3
$57K Hold
700
0.04% 173
2021
Q2
$64K Hold
700
0.04% 164
2021
Q1
$60K Sell
700
-1,000
-59% -$89.7K 0.04% 155
2020
Q4
$161K Hold
1,700
0.13% 81
2020
Q3
$148K Hold
1,700
0.13% 88
2020
Q2
$148K Hold
1,700
0.14% 85
2020
Q1
$140K Hold
1,700
0.16% 76
2019
Q4
$161K Hold
1,700
0.14% 70
2019
Q3
$148K Hold
1,700
0.14% 70
2019
Q2
$155K Sell
1,700
-197
-10% -$16.7K 0.15% 67
2019
Q1
$163K Hold
1,897
0.16% 65
2018
Q4
$146K Hold
1,897
0.17% 68
2018
Q3
$146K Hold
1,897
0.14% 79
2018
Q2
$128K Hold
1,897
0.13% 81
2018
Q1
$137K Hold
1,897
0.15% 77
2017
Q4
$143K Hold
1,897
0.15% 80
2017
Q3
$146K Hold
1,897
0.16% 73
2017
Q2
$142K Hold
1,897
0.16% 72
2017
Q1
$126K Hold
1,897
0.15% 79
2016
Q4
$124K Buy
+1,897
New +$123K 0.14% 79

Other funds holding NVS

Cordasco Financial Network's NVS Position: Q2 2022 in Review

Cordasco Financial Network held its Novartis (NVS) position steady in Q2 2022 at 700 shares worth $59K. The position accounts for 0.04% of the portfolio, ranked #174.

Cordasco Financial Network first reported a position in NVS in Q4 2016 and has held it in 23 quarters since. The position peaked at $163K in Q1 2019. 1,141 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

  • Cordasco Financial Network held 700 shares of Novartis worth $59K as of Q2 2022.
  • Cordasco Financial Network left its Novartis share count unchanged in Q2 2022.
  • Novartis made up 0.04% of Cordasco Financial Network's portfolio in Q2 2022, its #174 holding.
  • Cordasco Financial Network first reported a position in Novartis in Q4 2016 and has held it in 23 quarters since.
  • Cordasco Financial Network's Novartis position peaked at $163K in Q1 2019.
  • 1,141 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.